Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
Crown Castle
CCI
|
+$539M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$389M |
| 3 |
Energy Select Sector SPDR Fund
XLE
|
+$384M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$378M |
| 5 |
Medtronic
MDT
|
+$377M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.61B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.02B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$953M |
| 4 |
Merck
MRK
|
+$597M |
| 5 |
Johnson & Johnson
JNJ
|
+$589M |
Sector Composition
| 1 | Technology | 11.22% |
| 2 | Healthcare | 10.88% |
| 3 | Energy | 10.76% |
| 4 | Financials | 10.21% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Seaboard Corp
SEB
$3.78B
| $213K | ﹤0.01% |
51
-17
| -25% | -$71K |
|
|
PTNR
3802
DELISTED
Partner Communications
PTNR
| $212K | ﹤0.01% |
42,070
-21,551
| -34% | -$109K |
|
3803
Energy Recovery
ERII
$764M
| $211K | ﹤0.01% |
40,117
-343
| -0.8% | -$1.8K |
|
3804
Sonida Senior Living
SNDA
$500M
| $211K | ﹤0.01% |
568
-3,287
| -85% | -$1.22M |
|
|
DPG
3805
Duff & Phelps Utility and Infrastructure Fund
DPG
$463M
| $210K | ﹤0.01% |
9,787
| – | – |
|
|
ADMS
3806
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $210K | ﹤0.01% |
12,135
+8,187
| +207% | +$142K |
|
|
BT
3807
DELISTED
BT Group plc (ADR)
BT
| $210K | ﹤0.01% |
6,802
-81,380
| -92% | -$2.51M |
|
|
BBRG
3808
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $210K | ﹤0.01% |
15,179
+10,189
| +204% | +$141K |
|
|
KFX
3809
DELISTED
KOFAX LIMITED COM STK
KFX
| $210K | ﹤0.01% |
29,947
+23,787
| +386% | +$167K |
|
3810
BlackRock Enhanced Captial and Income Fund
CII
$936M
| $209K | ﹤0.01% |
15,005
+200
| +1% | +$2.79K |
|
|
DRD
3811
DRDGold
DRD
$1.93B
| $209K | ﹤0.01% |
136,377
+136,374
| +4,545,800% | +$209K |
|
|
NOA
3812
North American Construction
NOA
$399M
| $209K | ﹤0.01% |
66,790
+66,467
| +20,578% | +$208K |
|
3813
NWPX Infrastructure, Inc. Common Stock
NWPX
$495M
| $209K | ﹤0.01% |
6,983
+2,391
| +52% | +$71.6K |
|
3814
MidWestOne Financial Group
MOFG
$604M
| $208K | ﹤0.01% |
7,276
+272
| +4% | +$7.78K |
|
3815
Middlesex Water
MSEX
$971M
| $208K | ﹤0.01% |
9,119
+3,352
| +58% | +$76.5K |
|
|
JOBS
3816
DELISTED
51job, Inc.
JOBS
| $208K | ﹤0.01% |
5,816
+4,259
| +274% | +$152K |
|
|
SASR
3817
DELISTED
Sandy Spring Bancorp Inc
SASR
| $207K | ﹤0.01% |
7,956
-17,045
| -68% | -$443K |
|
|
LAYN
3818
DELISTED
Layne Christensen Co
LAYN
| $207K | ﹤0.01% |
21,833
-6,506
| -23% | -$61.7K |
|
|
AY
3819
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $206K | ﹤0.01% |
7,599
+7,595
| +189,875% | +$206K |
|
3820
MGP Ingredients
MGPI
$596M
| $205K | ﹤0.01% |
13,001
+12,901
| +12,901% | +$203K |
|
|
ACW
3821
DELISTED
Accuride Corp
ACW
| $205K | ﹤0.01% |
47,604
+24,328
| +105% | +$105K |
|
|
SAAS
3822
DELISTED
inContact, Inc.
SAAS
| $203K | ﹤0.01% |
23,238
-23,151
| -50% | -$202K |
|
3823
CRA International
CRAI
$1.3B
| $202K | ﹤0.01% |
6,671
+6,381
| +2,200% | +$193K |
|
3824
iShares Core S&P US Growth ETF
IUSG
$25.3B
| $202K | ﹤0.01% |
+5,174
| New | +$202K |
|
3825
Lexicon Pharmaceuticals
LXRX
$418M
| $202K | ﹤0.01% |
31,831
+29,750
| +1,430% | +$189K |
|